clofibrate has been researched along with Stevens-Johnson Syndrome in 1 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, SS | 1 |
1 other study available for clofibrate and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Stevens-Johnson syndrome induced by clofibrate.
Topics: Adult; Clofibrate; Deglutition Disorders; Follow-Up Studies; Humans; Hypertriglyceridemia; Male; Ste | 1994 |